Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tasisulam in metastatic breast cancer
NCT00992225Phase 2Completed
- Sponsor
- Eli Lilly and Company
- Start
- Sep 2009
- Primary completion
- Apr 2011
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of tasisulam in breast cancer, sponsored by Eli Lilly and Company. Started Sep 2009; status: completed.
02
Drugs
tasisulam
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT00992225.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00992225.